← back to search

Krai Chatamra

AbbVie (United States) · US
Area of research
Neurology · Speech and Hearing
Research interest
Research interests include Medicine, Carbidopa, Levodopa, Parkinson's disease, Dyskinesia, and Placebo.
h-index
citations
1,302
works
6
NIH funding
primary concept
email

Recent publications

Long‐term safety and efficacy of levodopa‐carbidopa intestinal gel in advanced Parkinson's disease
Movement Disorders 2018cited by 93position: middledoi
Effect of Levodopa‐carbidopa Intestinal Gel on Non‐motor Symptoms in Patients with Advanced Parkinson's Disease
Movement Disorders Clinical Practice 2017cited by 61position: middledoi
Levodopa‐carbidopa intestinal gel in advanced Parkinson's disease: Final 12‐month, open‐label results
Movement Disorders 2014cited by 237position: middledoi
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study
The Lancet Neurology 2013cited by 690position: middledoi
Levodopa–carbidopa intestinal gel in advanced Parkinson's disease open-label study: Interim results
Parkinsonism & Related Disorders 2013cited by 100position: middledoi
Pharmacokinetics of Levodopa, Carbidopa, and 3-O-Methyldopa Following 16-hour Jejunal Infusion of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson’s Disease Patients
The AAPS Journal 2012cited by 121position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Janet Benesh · AbbVie (United States)5 papers (2013–2018)David G. Standaert · University of Alabama at Birmingham5 papers (2013–2018)Alberto J. Espay · University of Cincinnati4 papers (2013–2018)Per Odin · Lund University4 papers (2012–2014)Weining Robieson · AbbVie (United States)3 papers (2013–2018)Coleen Hall · AbbVie (United States)3 papers (2014–2018)Hubert H. Fernandez · Universidade Federal do Rio Grande do Sul3 papers (2013–2018)Arvydas Vanagunas · Northwestern University3 papers (2013–2018)Yili Pritchett · AbbVie (United States)2 papers (2013–2013)Ahmed A. Othman · Gilead Sciences (Spain)2 papers (2012–2013)Ramon L. Rodriguez · University of Central Florida2 papers (2017–2018)Maurizio Facheris · AbbVie (United States)2 papers (2017–2018)Robert A. Hauser · University of South Florida2 papers (2013–2014)Robert Lenz · University of Rostock2 papers (2013–2013)John T. Slevin · University of Kentucky2 papers (2017–2018)Susan Eaton · Case Western Reserve University2 papers (2017–2018)Victor S.C. Fung · The University of Sydney2 papers (2014–2018)Mark Lew · LAC+USC Medical Center2 papers (2014–2018)Karl Kieburtz · Beth Israel Deaconess Medical Center1 papers (2013–2013) · 1 papers (2017–2017)